Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Four-amino acid part makes enzyme sensitive to finasteride.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Finasteride, a medication, is being re-evaluated for its effects and uses.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

5-ARI therapy may help prevent prostate cancer progression.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The market for these drugs is expected to grow.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

New compounds may soon be tested to treat excessive hair growth in women.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.